Review



pcmv6 src  (OriGene)


Bioz Verified Symbol OriGene is a verified supplier
Bioz Manufacturer Symbol OriGene manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    OriGene pcmv6 src
    Pcmv6 Src, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/c-src/SRC+(NM_005417)+Human+Tagged+ORF+Clone+Lentiviral+Particle/pmc06207713-213-4-5
    Average 90 stars, based on 1 article reviews
    pcmv6 src - by Bioz Stars, 2026-11
    90/100 stars

    Images

    Related Articles

    Stable Transfection:

    Article Title: Direct cysteine sulfenylation drives activation of the Src kinase
    Article Snippet: Src-FLAG constructs were transiently transfected into NCI-H292 pulmonary mucoepidermoid cells (ATCC) at 85–90% confluence using the Turbofect reagent (Thermo) according to a modified version of the manufacturer’s protocol.Src-FLAG constructs were transiently transfected into NCI-H292 pulmonary mucoepidermoid cells (ATCC) at 85–90% confluence using the Turbofect reagent (Thermo) according to a modified version of the manufacturer’s protocol.. Briefly, 1 μg of pCMV6-Src (Origene) was mixed with 8 μL Turbofect and 100 μL serum-free RPMI media (per well) and allowed to incubate at RT for 20 min.. Cells were changed to 900 μL serum-free media prior to dropwise addition of 100 μL transfection mix.Cells were changed to 900 μL serum-free media prior to dropwise addition of 100 μL transfection mix.

    Expressing:

    Article Title: Direct cysteine sulfenylation drives activation of the Src kinase
    Article Snippet: Src-FLAG constructs were transiently transfected into NCI-H292 pulmonary mucoepidermoid cells (ATCC) at 85–90% confluence using the Turbofect reagent (Thermo) according to a modified version of the manufacturer’s protocol.Src-FLAG constructs were transiently transfected into NCI-H292 pulmonary mucoepidermoid cells (ATCC) at 85–90% confluence using the Turbofect reagent (Thermo) according to a modified version of the manufacturer’s protocol.. Briefly, 1 μg of pCMV6-Src (Origene) was mixed with 8 μL Turbofect and 100 μL serum-free RPMI media (per well) and allowed to incubate at RT for 20 min.. Cells were changed to 900 μL serum-free media prior to dropwise addition of 100 μL transfection mix.Cells were changed to 900 μL serum-free media prior to dropwise addition of 100 μL transfection mix.

    Generated:

    Article Title: Direct cysteine sulfenylation drives activation of the Src kinase
    Article Snippet: Src-FLAG constructs were transiently transfected into NCI-H292 pulmonary mucoepidermoid cells (ATCC) at 85–90% confluence using the Turbofect reagent (Thermo) according to a modified version of the manufacturer’s protocol.Src-FLAG constructs were transiently transfected into NCI-H292 pulmonary mucoepidermoid cells (ATCC) at 85–90% confluence using the Turbofect reagent (Thermo) according to a modified version of the manufacturer’s protocol.. Briefly, 1 μg of pCMV6-Src (Origene) was mixed with 8 μL Turbofect and 100 μL serum-free RPMI media (per well) and allowed to incubate at RT for 20 min.. Cells were changed to 900 μL serum-free media prior to dropwise addition of 100 μL transfection mix.Cells were changed to 900 μL serum-free media prior to dropwise addition of 100 μL transfection mix.

    Transfection:

    Article Title: Direct cysteine sulfenylation drives activation of the Src kinase
    Article Snippet: Src-FLAG constructs were transiently transfected into NCI-H292 pulmonary mucoepidermoid cells (ATCC) at 85–90% confluence using the Turbofect reagent (Thermo) according to a modified version of the manufacturer’s protocol.Src-FLAG constructs were transiently transfected into NCI-H292 pulmonary mucoepidermoid cells (ATCC) at 85–90% confluence using the Turbofect reagent (Thermo) according to a modified version of the manufacturer’s protocol.. Briefly, 1 μg of pCMV6-Src (Origene) was mixed with 8 μL Turbofect and 100 μL serum-free RPMI media (per well) and allowed to incubate at RT for 20 min.. Cells were changed to 900 μL serum-free media prior to dropwise addition of 100 μL transfection mix.Cells were changed to 900 μL serum-free media prior to dropwise addition of 100 μL transfection mix.

    Selection:

    Article Title: Direct cysteine sulfenylation drives activation of the Src kinase
    Article Snippet: Src-FLAG constructs were transiently transfected into NCI-H292 pulmonary mucoepidermoid cells (ATCC) at 85–90% confluence using the Turbofect reagent (Thermo) according to a modified version of the manufacturer’s protocol.Src-FLAG constructs were transiently transfected into NCI-H292 pulmonary mucoepidermoid cells (ATCC) at 85–90% confluence using the Turbofect reagent (Thermo) according to a modified version of the manufacturer’s protocol.. Briefly, 1 μg of pCMV6-Src (Origene) was mixed with 8 μL Turbofect and 100 μL serum-free RPMI media (per well) and allowed to incubate at RT for 20 min.. Cells were changed to 900 μL serum-free media prior to dropwise addition of 100 μL transfection mix.Cells were changed to 900 μL serum-free media prior to dropwise addition of 100 μL transfection mix.



    Similar Products

    93
    Santa Cruz Biotechnology phospho c src
    Phospho C Src, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/c-src/p-c-Src+Antibody/pmc13747172-66-8-13
    Average 93 stars, based on 1 article reviews
    phospho c src - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    97
    Santa Cruz Biotechnology c src
    C Src, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/c-src/c-Src+Antibody/pmc13747172-66-5-13
    Average 97 stars, based on 1 article reviews
    c src - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    97
    Santa Cruz Biotechnology src targeting sirna sc 5266
    Src Targeting Sirna Sc 5266, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/c-src/c-Src+Antibody/pmc13046926-253-2-8
    Average 97 stars, based on 1 article reviews
    src targeting sirna sc 5266 - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    97
    Santa Cruz Biotechnology anti src primary antibody
    Anti Src Primary Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/c-src/c-Src+Antibody/pm41872167-236-0-6
    Average 97 stars, based on 1 article reviews
    anti src primary antibody - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc phospho c src tyr416 d49g4 cell signaling technology
    Phospho C Src Tyr416 D49g4 Cell Signaling Technology, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/c-src/10__3390_slash_cancers18071082-84-3-6
    Average 86 stars, based on 1 article reviews
    phospho c src tyr416 d49g4 cell signaling technology - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc c src family phospho tyr416
    C Src Family Phospho Tyr416, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/c-src/Phospho-Src+Family+(Tyr416)+Rabbit+mAb/pm41871717-58-48-63
    Average 96 stars, based on 1 article reviews
    c src family phospho tyr416 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    94
    ABclonal Biotechnology c src
    C Src, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/c-src/%5BKO+Validated%5D+Src+Rabbit+mAb/pm41825701-62-38-61
    Average 94 stars, based on 1 article reviews
    c src - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc c src y416
    Cav1 tyrosine (Y)-14 phosphorylation induced by APC–PAR1 is mediated by c-Src. A – C, endothelial EA.hy926 cells were pretreated with dasatinib or DMSO prior to addition of APC. Cell lysates were then immunoblotted to detect Cav1 Y14 and c-Src <t>Y416</t> phosphorylation as indicated. D – G, endothelial cells transfected with nonspecific (NS) or c-Src-specific siRNA were treated with or without APC, lysed, and immunoblotted as indicated. β-tubulin and GAPDH were used as loading controls. The data were quantified (mean ± SD) from four independent biological replicates and expressed as the fraction relative to the untreated control and analyzed by two-way ANOVA followed by Šídák's multiple comparisons test. ( B ) ∗ p = 0.0136; ( C ) ∗∗ p = 0.0038; ( F ) ∗∗∗ p = 0.0003; and ( G ) ∗ p = 0.0125. Student's unpaired t test, ( E ) ∗∗∗ p = 0.0002. APC, activated protein C; Cav1, caveolin-1; DMSO, dimethyl sulfoxide; PAR1, protease-activated receptor 1.
    C Src Y416, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/c-src/Phospho-Src+Family+(Tyr416)+Antibody/pmc12925215-265-32-34
    Average 96 stars, based on 1 article reviews
    c src y416 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc anti c src
    Cav1 tyrosine (Y)-14 phosphorylation induced by APC–PAR1 is mediated by c-Src. A – C, endothelial EA.hy926 cells were pretreated with dasatinib or DMSO prior to addition of APC. Cell lysates were then immunoblotted to detect Cav1 Y14 and c-Src <t>Y416</t> phosphorylation as indicated. D – G, endothelial cells transfected with nonspecific (NS) or c-Src-specific siRNA were treated with or without APC, lysed, and immunoblotted as indicated. β-tubulin and GAPDH were used as loading controls. The data were quantified (mean ± SD) from four independent biological replicates and expressed as the fraction relative to the untreated control and analyzed by two-way ANOVA followed by Šídák's multiple comparisons test. ( B ) ∗ p = 0.0136; ( C ) ∗∗ p = 0.0038; ( F ) ∗∗∗ p = 0.0003; and ( G ) ∗ p = 0.0125. Student's unpaired t test, ( E ) ∗∗∗ p = 0.0002. APC, activated protein C; Cav1, caveolin-1; DMSO, dimethyl sulfoxide; PAR1, protease-activated receptor 1.
    Anti C Src, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/c-src/pmc12925215-265-36-37
    Average 86 stars, based on 1 article reviews
    anti c src - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    Image Search Results


    Cav1 tyrosine (Y)-14 phosphorylation induced by APC–PAR1 is mediated by c-Src. A – C, endothelial EA.hy926 cells were pretreated with dasatinib or DMSO prior to addition of APC. Cell lysates were then immunoblotted to detect Cav1 Y14 and c-Src Y416 phosphorylation as indicated. D – G, endothelial cells transfected with nonspecific (NS) or c-Src-specific siRNA were treated with or without APC, lysed, and immunoblotted as indicated. β-tubulin and GAPDH were used as loading controls. The data were quantified (mean ± SD) from four independent biological replicates and expressed as the fraction relative to the untreated control and analyzed by two-way ANOVA followed by Šídák's multiple comparisons test. ( B ) ∗ p = 0.0136; ( C ) ∗∗ p = 0.0038; ( F ) ∗∗∗ p = 0.0003; and ( G ) ∗ p = 0.0125. Student's unpaired t test, ( E ) ∗∗∗ p = 0.0002. APC, activated protein C; Cav1, caveolin-1; DMSO, dimethyl sulfoxide; PAR1, protease-activated receptor 1.

    Journal: The Journal of Biological Chemistry

    Article Title: Activated protein C drives β-arrestin-2- and c-Src-dependent phosphorylation of Cav1 and modulates Cav1 association with PAR1 and GRK5

    doi: 10.1016/j.jbc.2026.111190

    Figure Lengend Snippet: Cav1 tyrosine (Y)-14 phosphorylation induced by APC–PAR1 is mediated by c-Src. A – C, endothelial EA.hy926 cells were pretreated with dasatinib or DMSO prior to addition of APC. Cell lysates were then immunoblotted to detect Cav1 Y14 and c-Src Y416 phosphorylation as indicated. D – G, endothelial cells transfected with nonspecific (NS) or c-Src-specific siRNA were treated with or without APC, lysed, and immunoblotted as indicated. β-tubulin and GAPDH were used as loading controls. The data were quantified (mean ± SD) from four independent biological replicates and expressed as the fraction relative to the untreated control and analyzed by two-way ANOVA followed by Šídák's multiple comparisons test. ( B ) ∗ p = 0.0136; ( C ) ∗∗ p = 0.0038; ( F ) ∗∗∗ p = 0.0003; and ( G ) ∗ p = 0.0125. Student's unpaired t test, ( E ) ∗∗∗ p = 0.0002. APC, activated protein C; Cav1, caveolin-1; DMSO, dimethyl sulfoxide; PAR1, protease-activated receptor 1.

    Article Snippet: In this study, the following antibodies were used: mouse anti–PAR1 WEDE (Beckman Coulter, #IM2584), anti-Cav1 (CST, #3267S and BD, #610060), anti-Cav1 Y14 phospho antibody (CST, #3251), anti-βarr2 (Abcam, #ab54790), GAPDH (GeneTex, #GT239), c-Src Y416 (CST, #2101), anti-c-Src (CST, #2109), GRK5 (Santa Cruz, #sc-518005), GRK5 polyclonal antibody (Invitrogen, #PA5-96262) anti-GRK4-6 (Millipore, #05-466), anti-HA (CST, #3724S), anti-rabbit IgG (CST, #2729), anti-β-Tubulin (CST, #86298), anti–early endosome antigen-1 (BD Biosciences, #610457), anti-Vinculin (Sigma, #V9131), and anti-HA conjugated to horseradish peroxidase (Roche, #11667475001).

    Techniques: Phospho-proteomics, Transfection, Control

    βarr2 is required for APC-stimulated c-Src tyrosine (Y)-416 phosphorylation and Cav1 Y14 phosphorylation. Endothelial EA.hy926 cells were transfected with nonspecific (NS) or βarr2-specific siRNA, treated with APC, and c-Src Y416 phosphorylation ( A and B ) and Cav1 Y14 phosphorylation ( C and D ) were detected by immunoblotting as indicated. GAPDH was used as a loading control. The data were quantified (mean ± SD) from four independent biological replicates and expressed as the fraction relative to the untreated control and analyzed by two-way ANOVA followed by Šídák's multiple comparisons test. B, NS siRNA with and without APC, ∗∗ p = 0.0097; ns = not significant. D, NS siRNA with and without APC ∗∗∗ p = 0.0009; βarr2 siRNA with and without APC, ∗∗ p = 0.0061. APC, activated protein C; βarr2, β-arrestin-2; Cav1, caveolin-1.

    Journal: The Journal of Biological Chemistry

    Article Title: Activated protein C drives β-arrestin-2- and c-Src-dependent phosphorylation of Cav1 and modulates Cav1 association with PAR1 and GRK5

    doi: 10.1016/j.jbc.2026.111190

    Figure Lengend Snippet: βarr2 is required for APC-stimulated c-Src tyrosine (Y)-416 phosphorylation and Cav1 Y14 phosphorylation. Endothelial EA.hy926 cells were transfected with nonspecific (NS) or βarr2-specific siRNA, treated with APC, and c-Src Y416 phosphorylation ( A and B ) and Cav1 Y14 phosphorylation ( C and D ) were detected by immunoblotting as indicated. GAPDH was used as a loading control. The data were quantified (mean ± SD) from four independent biological replicates and expressed as the fraction relative to the untreated control and analyzed by two-way ANOVA followed by Šídák's multiple comparisons test. B, NS siRNA with and without APC, ∗∗ p = 0.0097; ns = not significant. D, NS siRNA with and without APC ∗∗∗ p = 0.0009; βarr2 siRNA with and without APC, ∗∗ p = 0.0061. APC, activated protein C; βarr2, β-arrestin-2; Cav1, caveolin-1.

    Article Snippet: In this study, the following antibodies were used: mouse anti–PAR1 WEDE (Beckman Coulter, #IM2584), anti-Cav1 (CST, #3267S and BD, #610060), anti-Cav1 Y14 phospho antibody (CST, #3251), anti-βarr2 (Abcam, #ab54790), GAPDH (GeneTex, #GT239), c-Src Y416 (CST, #2101), anti-c-Src (CST, #2109), GRK5 (Santa Cruz, #sc-518005), GRK5 polyclonal antibody (Invitrogen, #PA5-96262) anti-GRK4-6 (Millipore, #05-466), anti-HA (CST, #3724S), anti-rabbit IgG (CST, #2729), anti-β-Tubulin (CST, #86298), anti–early endosome antigen-1 (BD Biosciences, #610457), anti-Vinculin (Sigma, #V9131), and anti-HA conjugated to horseradish peroxidase (Roche, #11667475001).

    Techniques: Phospho-proteomics, Transfection, Western Blot, Control

    Model of PAR1–GRK5–βarr2–c-Src regulation by Cav1. A substantial population of PAR1–Cav1 and GRK5–Cav1 complexes coexist at the plasma membrane under basal conditions. APC bound to EPCR cleaves and activates PAR1, resulting in GRK5-dependent phosphorylation of the receptor C-terminal tail within 30 min. This may occur during a time when GRK5 dissociates from Cav1. Next, APC-activated and phosphorylated PAR1 recruits βarr2, which promotes activation of c-Src Y416 phosphorylation and c-Src-dependent Cav1 Y14 phosphorylation, a process that occurs after 30 min and is sustained through 90 min. At 30 min, GRK5–Cav1 may reassociate, whereas activated PAR1 and Y14 phosphorylated Cav1 remain dissociated through the 90 min interval. APC, activated protein C; βarr2, βarr2; Cav1, caveolin-1; EPCR, endothelial protein C receptor; GRK5, GPCR kinase 5; PAR1, protease-activated receptor-1.

    Journal: The Journal of Biological Chemistry

    Article Title: Activated protein C drives β-arrestin-2- and c-Src-dependent phosphorylation of Cav1 and modulates Cav1 association with PAR1 and GRK5

    doi: 10.1016/j.jbc.2026.111190

    Figure Lengend Snippet: Model of PAR1–GRK5–βarr2–c-Src regulation by Cav1. A substantial population of PAR1–Cav1 and GRK5–Cav1 complexes coexist at the plasma membrane under basal conditions. APC bound to EPCR cleaves and activates PAR1, resulting in GRK5-dependent phosphorylation of the receptor C-terminal tail within 30 min. This may occur during a time when GRK5 dissociates from Cav1. Next, APC-activated and phosphorylated PAR1 recruits βarr2, which promotes activation of c-Src Y416 phosphorylation and c-Src-dependent Cav1 Y14 phosphorylation, a process that occurs after 30 min and is sustained through 90 min. At 30 min, GRK5–Cav1 may reassociate, whereas activated PAR1 and Y14 phosphorylated Cav1 remain dissociated through the 90 min interval. APC, activated protein C; βarr2, βarr2; Cav1, caveolin-1; EPCR, endothelial protein C receptor; GRK5, GPCR kinase 5; PAR1, protease-activated receptor-1.

    Article Snippet: In this study, the following antibodies were used: mouse anti–PAR1 WEDE (Beckman Coulter, #IM2584), anti-Cav1 (CST, #3267S and BD, #610060), anti-Cav1 Y14 phospho antibody (CST, #3251), anti-βarr2 (Abcam, #ab54790), GAPDH (GeneTex, #GT239), c-Src Y416 (CST, #2101), anti-c-Src (CST, #2109), GRK5 (Santa Cruz, #sc-518005), GRK5 polyclonal antibody (Invitrogen, #PA5-96262) anti-GRK4-6 (Millipore, #05-466), anti-HA (CST, #3724S), anti-rabbit IgG (CST, #2729), anti-β-Tubulin (CST, #86298), anti–early endosome antigen-1 (BD Biosciences, #610457), anti-Vinculin (Sigma, #V9131), and anti-HA conjugated to horseradish peroxidase (Roche, #11667475001).

    Techniques: Clinical Proteomics, Membrane, Phospho-proteomics, Activation Assay